Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06567067 · ClinicalTrials.gov registry record

Human Factoring Validation of Pulsenmore ES Device

A clinical trial, sponsored by PulseNmore.

Completed
Registry status
57
Enrollment target

NCT06567067 is a clinical trial that has completed, run by PulseNmore. The registered enrollment target is 57 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06567067 has completed, sponsored by PulseNmore.

COMPLETED
Registry status
57 participants
Enrollment target

Study Summary

The goal of this study is to conduct human factors validation testing with the Pulsenmore ES home Ultrasound device in the video-guided mode of operation (participants) and the clinician-guided mode of operation (participants and healthcare professionals (HCP)) to evaluate whether the device/user interface can be used by the intended users without any serious issues or errors under that intended use and actual use conditions. The intended users will be qualitatively assessed via observation and cognitive debrief and usability testing methodology. Participants will be remotely observed during the video-guided fetal scanning actual process and participants and HCPs will be remotely observed during the clinician-guided fetal scanning actual process.

Interventions

  • DEVICE Pulsenmore ES home ultrasound

Trial Details

FieldValue
Enrollment Target 57 participants
Start Date 2023-02-09
Est. Completion 2023-12-21

Sponsor

PulseNmore

3 total trials

What the Registry Record Tells You About NCT06567067

The ClinicalTrials.gov registry entry for NCT06567067 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is PulseNmore, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Pulsenmore ES home ultrasound is the first listed.

NCT06567067 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06567067 about?

NCT06567067 is a clinical study titled "Human Factoring Validation of Pulsenmore ES Device". The goal of this study is to conduct human factors validation testing with the Pulsenmore ES home Ultrasound device in the video-guided mode of operation (participants) and the clinician-guided mode of operation (participants and healthcare professionals (HCP)) to evaluate whether the device/user in...

What is the current status of trial NCT06567067?

This trial is currently completed. The enrollment target is 57 participants. The study started on 2023-02-09. Estimated completion is 2023-12-21.

What interventions are being tested in trial NCT06567067?

The interventions under investigation include: Pulsenmore ES home ultrasound (DEVICE).

Who is sponsoring clinical trial NCT06567067?

This trial is sponsored by PulseNmore, which has 3 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.